|
|
|
| Clinical study of radiation pneumonitis in patients with esophageal cancer and diabetes after intensity-modulated radiotherapy |
| GUO Feng, DU Aonan, SHI Jinglei, SHEN Wenbin, LIU Yazhou, SUN Suping |
| Department of Radiation Oncology, Xuzhou Cancer Hospital, Xuzhou 221005 China |
|
|
|
|
Abstract Objective To analyze the accidence of radiation pneumonitis in patients with esophageal cancer with diabetes mellitus after intensity-modulated radiotherapy.Methods A retrospective analysis was performed in xuzhou tumor hospital from June 2015 to June 2017. 50 cases of diabetic patients with esophageal cancer as experimental group and 50 patients with non-diabetic esophageal cancer were selected as control group. The incidence of radiation pneumonia in patients with esophageal cancer was compared between the two groups.Result In the experimental group, the incidence of radiation pneumonitis was 34% in patients with esophageal cancer after IMRT. In the control group, the incidence of radiation pneumonitis was 14% after treatment. There were significant differences in incidence of radiation pneumonitis between two groups of esophageal cancer patients(P<0.05).Conclusion The incidence of radiation pneumonitis is more common in patients with esophageal cancer with diabetes after intensity modulated radiation therapy.
|
|
Received: 09 May 2018
|
|
|
|
|
|
[1] Lutz SZ,Staiger H,Fritsche A,et al.Antihyperglycaemictherapiesand cancer risk[J].Diab Vasc Dis Res,2014,11(6):371-389.
[2] 朱莉菲,张秋玲.糖尿病与恶性肿瘤的相关性研究进展[J].医学综述,2017,23(13).
[3] 萧丽军,缪珩,祝群,等.2型糖尿病并发恶性肿瘤的风险因素分析[J].中国糖尿病杂志,2013,21(2):169-171.
[4] 韩蕾,卢冰,付和谊,等. Ⅲb~Ⅳ期非小细胞肺癌同期放化疗临床因素与放射性肺炎相关性研究[J].中华放射肿瘤学杂志, 2011,20(1):23-26.
[5] Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CACancerJClin,2015,65(2):87-108.
[6] Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CACancerJClin,2015,65(2):87-108.
[7] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J].CACancerJClin,2016,66(2):115-132.
[8] Wei WQ, Yang J, Zhang SW, et al. Analysis of the esophageal cancer mortality in 2004-2005 and its trends during last 30 years in China[J]. Zhonghua Yu Fang Yi Xue Za Zhi, 2010, 44(5):398-402.
[9] Marks LB,Bentzen SM,Deasy JO, et al.Radiation dose-volume effect in the lung[J].Int JR adiat Oncol Biol Phs,2010,76(3):70-76.
[10] 陈凤,李全福,金高娃,等.重组人粒细胞刺激因子治疗急性放射性黏膜炎的疗效观察[J].中国辐射卫生,2016,25(6):749-752.
[11] 祖国红,李福生,王厚伟.放射防护膏(Rp)对乳腺癌皮肤放疗反应的疗效观察[J].中国辐射卫生, 2014,23(2):187-190.
[12] Plama DA,Senan S,Tsujino K,et al. Predicting radiation pneumonitis after chemoradiation therapy for lung cancer:An Internation Individal Patient Data Meta-analysis[J]. Int JR adiat Oncol Biol Phs,2013,87(4):690-696.
[13] 鲍艳红,黄常新.放射性肺炎的发病机制及其防治研究进展[J].实用医学杂志,2015,31(21):3621-3623.
[14] 陈伟,宫帅,尹静静,等.肺癌放射治疗致放射性肺炎的临床疗效分析[J].中国实用医药,2014,9(27):7-9.
[15] 陈静.肺癌放疗患者放射性肺炎优质护理的应用[J].中西医结合护理:中英文,2015,1(2):40-41.
[16] 陈多才,康兆君,李秀冬.肺癌伴糖尿病患者放射性肺炎发生率的临床观察[J].吉林医学,2012,33(8):1638-1639. |
|
|
|
